DYN Dyne Therapeutics, Inc.

Fundamentals / CIK 0001818794 / USD

Dyne Therapeutics, Inc. reported $1.23B in total assets and a net loss of $604.9M through December 31, 2025 from SEC EDGAR filings.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open DYN in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

7 fiscal years (2019 to 2025), reported in USD.

$0$0$0-$417.2MFY 2019 Net Income: -$14.86M2019FY 2020 Net Income: -$59.44M2020FY 2021 Net Income: -$149.3M2021FY 2022 Net Income: -$168.1M2022FY 2023 Net Income: -$235.9M2023FY 2024 Net Income: -$317.4M2024FY 2025 Net Income: -$446.2M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Research & Development $398.3M $281.4M $210.8M $142.8M $121.3M $45.20M $11.04M
Total Operating Expenses $468.2M $343.9M $242.2M $171.0M $150.0M $58.65M $13.83M
Operating Income -$468.2M -$343.9M -$242.2M -$171.0M -$150.0M -$58.65M -$13.83M
EBITDA -$466.1M -$342.2M -$240.5M -$169.3M -$148.9M -$57.95M -$13.55M
Interest Income $29.86M $26.92M $7.64M $2.92M $742K $56K $290K
Income Tax Expense $0 $0 $0 -- -- -- --
Net Income -$446.2M -$317.4M -$235.9M -$168.1M -$149.3M -$59.44M -$14.86M
Basic EPS -$3.47 -$3.37 -$3.95 -$3.23 -$2.93 -$4.13 -$6.08
Diluted EPS -$3.47 -$3.37 -$3.95 -$3.23 -$2.93 -$4.13 -$6.08
Basic Shares Outstanding -- -- -- -- 50.9M 14.4M 2.4M
Diluted Shares Outstanding -- -- -- -- 50.9M 14.4M 2.4M

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Research & Development $161.7M $152.2M $100.9M $95.43M $97.22M $99.24M $106.4M $81.81M
Total Operating Expenses $197.1M $181.7M $125.3M $116.1M $113.9M $115.8M $122.4M $97.11M
Operating Income -$197.1M -$181.7M -$125.3M -$116.1M -$113.9M -$115.8M -$122.4M -$97.11M
EBITDA -$196.5M -$181.1M -$124.7M -$115.6M -$113.4M -$115.3M -$121.9M -$96.66M
Interest Income $9.77M $7.79M $8.76M $7.66M $8.48M $6.62M $7.10M $7.59M
Interest Expense -- -- -- -- $2.90M $94K -- --
Net Income -$193.6M -$178.6M -$120.9M -$112.0M -$108.0M -$110.9M -$115.4M -$89.54M
Basic EPS -$1.06 -$1.08 -$0.73 -- -$0.76 -$0.97 -$1.05 --
Diluted EPS -$1.06 -$1.08 -$0.73 -- -$0.76 -$0.97 -$1.05 --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $893.4M $435.4M $121.6M $172.1M $200.8M $300.9M $14.63M
Short-Term Investments $217.2M $206.8M $1.47M $83.86M $175.7M $44.46M $0
Cash & Short-Term Investments $1.11B $642.3M $123.1M $256.0M $376.6M $345.3M $14.63M
Total Current Assets $1.13B $659.3M $129.4M $265.6M $382.4M $349.1M $14.76M
Property, Plant & Equipment, Net $24.03M $5.40M $4.78M $5.95M $4.68M $1.95M $1.49M
Other Non-Current Assets -- -- -- -- -- -- $191K
Total Non-Current Assets $31.20M $31.95M $35.71M $40.73M $43.27M $4.25M $1.68M
Total Assets $1.19B $691.2M $165.1M $306.3M $425.7M $353.3M $16.44M
Accounts Payable $8.08M $6.56M $22.94M $5.26M $4.03M $3.44M $1.26M
Total Current Liabilities $50.62M $42.26M $51.09M $28.09M $28.72M $10.97M $2.36M
Long-Term Debt $148.9M $0 -- -- -- -- --
Total Non-Current Liabilities $164.2M $19.14M $22.70M $25.87M $28.74M $0 $42K
Total Liabilities $214.8M $61.40M $73.79M $53.96M $57.47M $10.97M $2.40M
Total Debt (incl. Leases) $169.2M $23.99M $27.41M $30.48M $32.64M -- --
Common Stock $16K $10K $6.0K $6.0K $6.0K $5.0K $1.0K
Retained Earnings -$1.40B -$949.9M -$632.5M -$396.6M -$228.5M -$79.18M -$19.75M
Accumulated Other Comp. Income $475K $6.0K $0 -$571K -$269K -$27K --
Total Stockholders' Equity $972.1M $629.8M $91.29M $252.4M $368.2M $342.4M $14.04M
Total Equity $972.1M $629.8M $91.29M $252.4M $368.2M $342.4M $14.04M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $913.2M $676.1M $753.1M $893.4M $573.6M $485.0M $472.3M $435.4M
Short-Term Investments $221.2M $222.4M $219.1M $217.2M $218.3M $198.9M $205.2M $206.8M
Cash & Short-Term Investments $1.13B $898.5M $972.2M $1.11B $791.9M $683.9M $677.5M $642.3M
Total Current Assets $1.18B $937.9M $1.02B $1.13B $806.3M $698.0M $689.5M $659.3M
Property, Plant & Equipment, Net $7.14M $24.56M $23.68M $24.03M $23.97M $5.67M $5.75M $5.40M
Other Non-Current Assets $18.80M -- -- -- -- -- -- --
Total Non-Current Assets $58.77M $56.12M $58.92M $31.20M $60.80M $31.04M $31.57M $31.95M
Total Assets $1.23B $994.0M $1.08B $1.19B $867.1M $729.0M $721.1M $691.2M
Accounts Payable $14.90M $12.15M $10.78M $8.08M $12.06M $14.02M $7.02M $6.56M
Total Current Liabilities $90.55M $78.03M $51.25M $50.62M $59.85M $41.47M $33.88M $42.26M
Long-Term Debt $200.0M $199.3M $149.4M $148.9M $99.15M $98.81M -- $0
Total Non-Current Liabilities $213.3M $213.8M $163.6M $164.2M $115.4M $116.1M $18.22M $19.14M
Total Liabilities $303.9M $291.9M $214.9M $214.8M $175.3M $157.5M $52.10M $61.40M
Total Debt (incl. Leases) $218.9M $219.2M $168.7M $169.2M $120.5M $121.1M $23.33M $23.99M
Common Stock $18K $16K $16K $16K $14K $11K $11K $10K
Retained Earnings -$1.89B -$1.70B -$1.52B -$1.40B -$1.28B -$1.18B -$1.07B -$949.9M
Accumulated Other Comp. Income -$1.00M -$353K -$137K $475K $496K $252K $241K $6.0K
Total Stockholders' Equity $930.9M $702.2M $865.1M $972.1M $691.8M $571.4M $669.0M $629.8M
Total Equity $930.9M $702.2M $865.1M $972.1M $691.8M $571.4M $669.0M $629.8M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$446.2M -$317.4M -$235.9M -$168.1M -$149.3M -$59.44M -$14.86M
Depreciation & Amortization $2.05M $1.67M $1.67M $1.68M $1.09M $700K $271K
Stock-Based Compensation $45.85M $45.86M $19.97M $15.18M $17.54M $6.59M $26K
Operating Cash Flow -$403.2M -$292.4M -$188.2M -$153.6M -$119.6M -$46.51M -$11.83M
Capital Expenditure -$1.92M -$2.38M -$729K -$3.07M -$3.62M -$1.16M -$1.65M
Free Cash Flow -$405.1M -$294.7M -$188.9M -$156.7M -$123.2M -$47.67M -$13.48M
Purchases of Investments -$180.5M -$317.4M -$44.26M -$121.2M -$236.7M -$44.50M --
Investing Cash Flow -$28.75M -$204.1M $83.31M $87.20M -$137.9M -$45.66M -$1.65M
Common Stock Issued $140.7M $97.87M $52.37M $36.86M -- -- --
Financing Cash Flow $890.3M $809.9M $54.32M $37.39M $157.8M $380.7M $19.99M
Net Change in Cash $458.3M $313.4M -$50.52M -$29.05M -$99.63M $288.5M $6.51M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$193.6M -$178.6M -$120.9M -$112.0M -$108.0M -$110.9M -$115.4M -$89.54M
Depreciation & Amortization $600K $600K $550K $521K $500K $500K $502K $450K
Stock-Based Compensation $16.21M $14.98M $13.08M $11.23M $11.08M $10.52M $13.02M $10.48M
Operating Cash Flow -$177.5M -$130.3M -$144.9M -$111.8M -$90.78M -$94.70M -$105.9M -$84.33M
Capital Expenditure -$2.01M -$1.51M -$221K -$484K -$395K -$60K -$981K -$1.07M
Free Cash Flow -$179.5M -$131.8M -$145.1M -$112.3M -$91.17M -$94.76M -$106.9M -$85.41M
Purchases of Investments -$51.56M -$42.79M -$64.28M -$26.71M -$46.92M -$40.93M -$65.97M -$52.71M
Investing Cash Flow -$1.29M -$4.79M -$2.39M $982K -$37.97M $6.77M $1.46M -$16.01M
Common Stock Issued $0 $0 $0 $0 $0 $0 $140.7M $0
Financing Cash Flow $418.1M $58.11M $7.06M $431.0M $217.3M $100.8M $141.2M $3.64M
Net Change in Cash $239.3M -$76.97M -$140.2M $320.1M $88.58M $12.85M $36.81M -$96.71M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Return on Equity (ROE) -45.9% -50.4% -258.4% -66.6% -40.5% -17.4% -105.9%
Return on Assets (ROA) -37.6% -45.9% -142.9% -54.9% -35.1% -16.8% -90.4%
Current Ratio 22.25x 15.60x 2.53x 9.46x 13.31x 31.83x 6.26x
Quick Ratio 21.94x 15.20x 2.41x 9.11x 13.11x 31.49x 6.21x
Debt to Equity 0.17x 0.04x 0.30x 0.12x 0.09x -- --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Return on Equity (ROE) -65.0% -74.0% -52.2% -45.9% -61.3% -72.3% -54.9% -50.4%
Return on Assets (ROA) -49.0% -52.3% -41.8% -37.6% -48.9% -56.6% -50.9% -45.9%
Current Ratio 12.99x 12.02x 19.92x 22.25x 13.47x 16.83x 20.35x 15.60x
Quick Ratio 12.53x 11.51x 18.97x 21.94x 13.23x 16.49x 20.00x 15.20x
Debt to Equity 0.24x 0.31x 0.19x 0.17x 0.17x 0.21x 0.03x 0.04x
Source: SEC EDGAR CompanyFacts (CIK 0001818794) · from March 31, 2019 Data through September 30, 2026 · synced Nov 20, 2026, 05:19 UTC · Open in terminal